Skip to content

Lactation Fortification Study

Impact of Nutrient Supplementation on Breast Milk Levels of Lactating Women

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01747668
Enrollment
89
Registered
2012-12-12
Start date
2012-11-30
Completion date
2013-04-30
Last updated
2013-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lactation

Keywords

Mother and Infant Pairs

Brief summary

To investigate the impact of nutrient supplementation during lactation on levels in breast milk.

Interventions

DIETARY_SUPPLEMENTSimilac Prenatal Vitamin soft-gel capsule

One capsule per day for Experimental Supplement A Group; Two capsules per day for Experimental Supplement B Group

DIETARY_SUPPLEMENTPlacebo (soybean oil and dl-alpha-tocopheryl acetate)

Two capsules per day for the Placebo Group; One capsule per day for the Experimental Group A

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Subjects will be eligible for the study if they meet all of the following inclusion criteria: 1. Mother with singleton birth, 37-42 weeks gestation and ≥ 2490g 2. Pre-pregnancy BMI \</= 30 3. Mother is ≥ 18 years of age 4. Mother is 4-6 weeks postpartum and has been successfully continuously lactating 5. Mother agrees to abstain from the use of any Docosahexaenoic acid (DHA), lutein and/or vitamin E containing supplements for at least 10 days prior to providing a baseline breast milk sample 6. Mother agrees to abstain from the use of non-study supplements throughout the study 7. Mother plans to continue breastfeeding for at least 6 weeks from the start of the study 8. No significant ongoing medical problems in the infant as determined from infant's medical history as related by the parent(s) to the enrolling center personnel

Exclusion criteria

Subjects will be excluded from the study if they meet any of the following criteria: 1. Subject had adverse maternal and/or fetal medical history 2. Subject is participating in a non-Abbott approved concomitant trial 3. Mother is taking cholesterol medication and/or medication affecting lipid absorption and/or transport

Design outcomes

Primary

MeasureTime frame
Breast milk concentration of carotenoids1 - 43 days

Secondary

MeasureTime frame
Breast milk concentration of fatty acids1 - 43 days

Other

MeasureTime frameDescription
Blood levels of nutrients and fatty acids1 and 43 daysIn mothers at 1 and 43 days In infants at 43 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026